Dr Saw Khay Yong Stem Cell Therapy for the Musculoskeletal System
By: Admin KLSMC
Read the original:
Dr Saw Khay Yong Stem Cell Therapy for the Musculoskeletal System - Video
Posted: November 13, 2014 at 6:44 am
Dr Saw Khay Yong Stem Cell Therapy for the Musculoskeletal System
By: Admin KLSMC
Read the original:
Dr Saw Khay Yong Stem Cell Therapy for the Musculoskeletal System - Video
Posted: November 13, 2014 at 2:44 am
Regenerating Brains with Stem Cells - Bernd Evert
Reprogramming stem cells is one of the most promising advance towards curing neurodegenerations, says Bernd Evert EU project: HIGHLIGHT (http://www.youris.co...
By: European health innovation transfer network
Follow this link:
Regenerating Brains with Stem Cells - Bernd Evert - Video
Posted: November 13, 2014 at 2:44 am
Kids get arthritis
http://www.anthonynolan.org/8-ways-you-could-save-life/donate-your-stem-cells/apply-join-our-register for people who might want to join the register to help adults and children like Alex.
By: LyndaM85
Posted: November 12, 2014 at 6:53 pm
When stem cells are propagated in the laboratory, they typically differentiate into one or another specialized cell type, usually forming cell masses that show little organization or spatial coherence. Exceptions include the emergence, in culture, of retinal and anterior cortex-like tissues. For the most part, however, stem cell aggregates in the laboratory prefer to remain lumps.
Despite coaxing, they refuse to organize themselves into structures that resemble embryos. In particular, they avoid taking the earliest steps of embryonic developmentaxis formation and gastrulation, the organized movement of cells that, using the initial axis as a reference, positions the head and the tail, the front and the back.
Now, however, researchers at the University of Cambridge have managed to reconstruct the early stages of mammalian development using mouse embryonic stem cells, showing that a critical mass of cellsnot too few, but not too manyis needed for the cells to begin self-organizing into the correct structure for an embryo to form. The researchers, led by Professor Alfonso Martinez-Arias, presented their finding in a pair of papers that appeared in the November issue of the journal Development.
In one article, Symmetry breaking, germ layer specification and axial organization in aggregates of mouse embryonic stem cells, the authors report that small aggregates of [mouse embryonic stem cells], of about 300 cells, self-organize into polarized structures that exhibit collective behaviors reminiscent of those that cells exhibit in early mouse embryos.
The researchers showed that if the number of cells aggregated initially is similar to that of a mouse embryo, the cells generate a single axis and this serves as a template for a sequence of events that mimics those of the early embryo. By manipulating the signals that the cells see at a particular time, the researchers were able to influence what type of cell they become and how they are organized. In one of the experiments, for example, activation of a particular signal at the correct time elicits the appearance of the mesoderm, endoderm, and ectodermthe precursors of all cell typeswith a spatial organization similar to that of an embryo.
In another article, Wnt/-catenin and FGF signalling direct the specification and maintenance of a neuromesodermal axial progenitor in ensembles of mouse embryonic stem cells, the authors detailed how a specialized population of cells emerges at the end of gastrulation that, under the influence of Wnt and FGF signaling, expands and generates the spinal cord and the paraxial mesoderm.
In other words, the researchers were able to generate the early stages of a spinal cord, which they showed forms as part of the process of gastrulation. This finding complements previous research from the University of Edinburgh and the National Institute for Medical Research showing that embryonic stem cells can be coaxed into becoming spinal cord cells; the Cambridge researchers went further, however, showing that in the embryo-like aggregates, the structural organization is more robust and allows for the polarized growth of the tissue.
It is early days, but this system promises insights into the early stages of development and what determines the specification of the different cell types, said Professor Martinez-Arias. This will allow more robust protocols for differentiation with cues that mimic those that the cells are subject to in embryos.
Most significantly, the system will provide a means to test, experimentally, how a homogeneous group of cells organizes itself in space, a central process in the development of any organism, and the ability to recreate in culture the niches that adult stem cells create during embryogenesis and which have remained elusive experimentally.
To enjoy more articles like this from GEN, click here to subscribe now
Follow this link:
Critical Mass of Stem Cells Sets Off Embryonic Development ...
Posted: November 12, 2014 at 6:53 pm
Bid Date & Time: 09/07/15 5:00 PM Owner Solic Number: PA-12-232Status: biddingReport: 5964454 Country :United States State: MDCounty: Montgomery Location: Bethesda Scope: This Funding Opportunity Announcement (FOA) encourages applications to study human and non-human stem cells involved in alcohol-induced tissue injuries. Alcohol abuse is known to cause pathology in a number of organ systems. Disorders most commonly associated with chronic alcohol consumption include alcoholic liver disease (ALD), pancreatitis, cardiovascular disease, neural damage, endocrine dysfunction, osteoporosis, cancer, and immune dysfunction. The objective of this FOA is to understand the role of stem cells in alcohol-induced tissue damage and recovery, particularly how they are influenced by alcohol metabolism and their role in alcohol-related cancers. Notes: If you have difficulty accessing the full announcement electronically, please contact: NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Plans: From Owner. See outside link. Outside Link: Owner Type: Public Buyer: National Institutes of Health (NIH) Address: 9000 Rockville Pike City: Bethesda State: MD Zip/Postal Code: 20892 Website: http://www.nih.gov Bid Pkg Source: National Institutes of Health (NIH) Address: 9000 Rockville Pike City: Bethesda State: MD Zip/Postal Code: 20892 Website: http://www.nih.gov
Follow this link:
Bid on Stem Cells and Alcohol-induced Tissue Injuries (R21 ...
Posted: November 12, 2014 at 6:51 pm
PUBLIC RELEASE DATE:
12-Nov-2014
Contact: Scott Maier scott.maier@ucsf.edu 415-502-6397 University of California - San Francisco @ucsf
A protein that may partly explain why human brains are larger than those of other animals has been identified by scientists from two stem-cell labs at UC San Francisco, in research published in the November 13, 2014 issue of Nature.
Key experiments by the UCSF researchers revealed that the protein, called PDGFD, is made in growing brains of humans, but not in mice, and appears necessary for normal proliferation of human brain stem cells growing in a lab dish.
The scientists made their discovery as part of research in which they identified genes that are activated to make specific proteins in crucial stem cells in the brain known as radial glial cells. The discovery stems from a collaboration between the laboratories of leading radial glial cell scientist Arnold Kriegstein MD, PhD, director of the Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research at UCSF, and Michael Oldham, PhD, who recently made a rapid career leap from graduate student to principal investigator and Sandler Fellow at UCSF.
Radial glial cells make the neurons in the growing brain, including the neurons in the cerebral cortex, the seat of higher brain functions. The cerebral cortex varies in size 10,000-fold among mammals. Changes in the timing, location and degree of cell division and nerve cell generation by radial glial cells can dramatically alter the shape and function of the cortex.
The UCSF team discovered that PDGFD is secreted by human radial glial cells and acts on radial glial cells as well as other progenitor cells in the developing brain.
"To the best of our knowledge this is the first example of any signaling pathway affecting the proliferation of radial glial cells whose activity has changed during mammalian evolution," Oldham said. "We think that the expression of PDGFD in this signaling pathway is likely to be part of the reason the human brain is so much bigger that the mouse brain."
Although the UCSF research team found that the majority of genes that are active in radial glial cells are the same in humans and mice, they identified 18 genes that are active in human but not mouse radial glial cells during development of the cerebral cortex.
View post:
Humans' big brains might be due in part to newly identified protein
Posted: November 12, 2014 at 6:46 pm
Nano cap InVivo Therapeutics (OTCQB:NVIV) continued its up move today with shares rising38%on a 10x surge in volume. Prices have almost tripled in a month as investor interest builds over its Neuro-Spinal Scaffold for the treatment of acute spinal cord injury. The first patient to receive the device is a 25-year old Scottsdale, AZ man who broke his back in a dirt bike accident last month. Although it's too early to gauge the success of the implant some researchers and clinicians believe it has great promise. In late October, the FDA approved an expansion of clinical trial sites from six to 20 and broadened patient eligibility criteria. After today's action, InVivo's market cap is $133M which is comparable to other regenerative medicine firms working on spinal cord injury therapies. For comparison purposes, the market valuations of Neuralstem (NYSEMKT:CUR), Asterias Biotherapeutics (NYSEMKT:AST) and StemCells (NASDAQ:STEM) are $256M, $125M and $80M, respectively. Share this with a colleague
View post:
InVivo Therapeutics
Posted: November 12, 2014 at 11:48 am
Research in pluripotent stem cells | Anna Veiga | TEDxReus
This talk was given at a local TEDx event, produced independently of the TED Conferences. What are stem cells? What is the current research and what are the ...
By: TEDx Talks
Read more here:
Research in pluripotent stem cells | Anna Veiga | TEDxReus - Video
Posted: November 12, 2014 at 11:48 am
CHENNAI: It is harder for natives of Tamil Nadu to find a matching donor for a stem cell transplant compared to other states in the country. The suspected villain: Their genes.
A study published recently in British medical journal 'The Lancet' found that the likelihood of finding a matching stem cell donor for patients with blood-related problems in Tamil Nadu is 44.2% provided the registry had 10 lakh donors. The situation is the opposite in Haryana, with people in that state having the best chances (81.2%) of finding a donor.
Experts say consanguineous marriages are to blame. Consanguineous marriages increase the chances of patients finding a match within their small community but limit the possibility of finding one from a general donor pool.
"Unlike in other countries, stem cell variation in India is complex and dependent on ethnic variation," said Dr Dolly Daniel, professor of the department of transfusion medicine at Christian Medical College, Vellore, who was party of the study team. "Our aim was to find the size and genetic composition of each region and its impact on the proportion of patients who will be able to ?nd a suitable match."
She said Tamil Nadu could be at the tail-end of the list of states they surveyed because of inbreeding and a limited number of donors.
Stem cells are used to regenerate and repair diseased or damaged tissues. Adult stem cells are drawn from bone marrow, blood and the umbilical cord and are used to treat blood-related ailments like leukemia, thalassemia and as well as immunodeficiency.
The possibility of finding a matching stem cell donor within the family is around 30%.
"Finding a matching stem cell donor for the remaining 70% is a complex process. Most seek a graft from registries of unrelated adult donors or banked umbilical cord blood units," said Dr P Srinivasan, co-founder and chairman of Jeevan Stem Cell Bank.
Although the India stem cell industry is estimated to touch $540 million (Rs 3,250 crore) by 2015, the study noted that in terms of the number of donors, India has lagged in meeting demand. The study surveyed 10 adult donor and umbilical cord bank registries and clinical transplant centres in India and studied stem cells of 26 239 individuals.
The possibility of finding a perfect match within India is an average of 14.4% for a registry size of 25,000 and touches 60.6% for a size of 10 lakh. Registries in the country currently have around 1 lakh donors. The study said only when Indian registries have more than 2 lakh donors would patients have a good chance of finding the right match.
Originally posted here:
Toughest for Tamil Nadu patients to get donor stem cells
Posted: November 12, 2014 at 11:48 am
Two Cambridge University scientists have launched a crowdfunding campaign to help develop their vision to build lung tissue in the lab. They believe the technology using stem cells could prove significant in combating lung cancer.
In a campaign supported by Cancer Research UK (CRUK), Dr Michaela Frye and Dr Ferda Oeztuerk-Winder are seeking to raise 75k on Indiegogo.
The money will cover the costs of growing and maintaining the lung tissue over the course of a year. Dr Frye said: Its no easy job, it takes researcher time and the careful construction of a bioreactor a smart piece of kit that creates the perfect conditions for growth.
The scientists have spent years studying cancer and felt it was time to tackle the biggest global cancer killer.
Dr Frye said: Lung cancer is highly aggressive and survival rates have remained stubbornly low over the past few decades. Our progress against it has not been fast enough. We want to change that.
But its no easy task; the lung is a complex organ and we struggle to see the full picture. Lung cancer is intelligent and to beat it we need to learn more about how it grows, how it develops and how it becomes resistant to treatments.
To gain a better understanding we are approaching the disease from a new angle. We recently revealed a type of cell in the lung called a stem cell. It has the ability to develop into many different types of cell found in the lung.
We want to grow these stem cells into a piece of 3D lung tissue in an instrument called a bioreactor. By using a bioreactor, we can create the perfect conditions to grow human lung tissue outside of the body. This process will give a 3D model to study what happens when lung cancer develops.
No cell acts alone. Cells communicate with each other all the time. Cells grown in 3D will give us a much clearer picture than those grown in a Petri dish. So we are aiming to shift the focus from the dish to actual lung tissue and introduce cancer cells to understand how they interact with the healthy lung cells.
By pledging towards this research backers will be supporting a groundbreaking new approach in the battle against cancer. Rewards are being offered as a token of the duos appreciation.You can pledge your support now athttps://www.indiegogo.com/projects/growing-3d-lung-tissue-in-the-lab-to-beat-cancer
Read more:
Scientists seek funds to grow lung tissue in the lab